Mylan Settles With Most Insurers In $67M Antitrust Appeal
Mylan Pharmaceuticals Inc. and a pair of chemical companies accused of a price-fixing scheme with the generic-drug maker have come to an undisclosed settlement with most of the insurers fighting to...To view the full article, register now.
Already a subscriber? Click here to view full article